We are looking for passionate scientists, AI engineers, and innovators to join our growing team.
Current Openings:
Please send your CV and cover letter to careers(at)magenta-octopus-243775.hostingersite.com
Dr. Gordon Ma is a geneticist, stem cell biologist, and biotech founder with over 20 years of experience in epigenetics, gene regulation, and rejuvenation biology. His PhD work produced the first evidence of CDH1 promoter methylation in precancerous tissue—a foundational contribution to modern epigenetics. He completed postdoctoral training at Harvard Medical School and the University of Colorado, where he studied XIST-mediated epigenetic regulation.
At the NIH (NHLBI), Dr. Ma conducted research in embryonic stem cell differentiation and cardiovascular regenerative biology and made key findings on mitochondrial regulation of pluripotency. He later founded several life science companies while continuing NIH research as a special volunteer for nearly a decade.
As Founder and CEO of Rejuve Therapeutics, Dr. Ma is the principal inventor of a patented method demonstrating gene-driven rejuvenation without dedifferentiation. His ongoing work includes large-scale single-cell sequencing studies and the development of the first Longitudinal Human Aging and Rejuvenation Gene Expression Atlas. He is collaborating closely with AI scientists on transfer learning and biological foundation models to identify key regulatory genes driving aging and rejuvenation and to develop clinically viable rejuvenation gene cocktails